Liver injury and disease pathogenesis in chronic hepatitis C

Current Topics in Microbiology and Immunology

Volumn 369, Issue , 2013, Pages 263-288

  Yamane, Daisuke ^a   McGivern, David R ^a   Masaki, Takahiro ^a   Lemon, Stanley M ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOTRANSFERASE; VIRUS PROTEIN;

ARTICLE; CARCINOGENESIS; CELL METABOLISM; CRYOGLOBULINEMIA; ENDOCRINE DISEASE; FATTY LIVER; GLOMERULONEPHRITIS; HEMATOLOGIC DISEASE; HEPATITIS C; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INSULIN RESISTANCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER INJURY; LYMPHOPROLIFERATIVE DISEASE; MORBIDITY; MORTALITY; NEUROLOGIC DISEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

HEPATITIS C VIRUS;

EID: 84876588538     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-27340-7_11     Document Type: Article

References (204)

1. Adinolfi LE, Gambardella M, Andreana A et al (2001) Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 33:1358-13644
2. Agnello V, Abel G (1997) Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum 40:2007-20155
3. Agnello V, Chung RT, Kaplan LM (1992) A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327:1490-14955
4. Ahmad J, Eng FJ, Branch AD (2011) HCV and HCC: clinical update and a review of HCCassociated viral mutations in the core gene. Semin Liver Dis 31:347-3555
5. Akuta N, Suzuki F, Kawamura Y et al (2007) Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis. Hepatology 46:1357-13644
6. Alonzi T, Agrati C, Costabile B et al (2004) Steatosis and intrahepatic lymphocyte recruitment in hepatitis C virus transgenic mice. J Gen Virol 85:1509-15200
7. Altlparmak E, Koklu S, Yalinkilic M et al (2005) Viral and host causes of fatty liver in chronic hepatitis B. World J Gastroenterol 11:3056-30599
8. Anderson EJ, Lustig ME, Boyle KE et al (2009) Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest 119:573-5811
9. Arase Y, Suzuki F, Suzuki Y et al (2009) Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C. Hepatology 49:739-7444
10. Aytug S, Reich D, Sapiro LE et al (2003) Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes. Hepatology 38:1384-13922
11. Banerjee S, Saito K, Ait-Goughoulte M et al (2008) Hepatitis C virus core protein upregulates serine phosphorylation of insulin receptor substrate-1 and impairs the downstream akt/protein kinase B signaling pathway for insulin resistance. J Virol 82:2606-26122
12. Banerjee A, Meyer K, Mazumdar B et al (2010) Hepatitis C virus differentially modulates activation of forkhead transcription factors and insulin-induced metabolic gene expression. J Virol 84:5936-59466
13. Barba G, Harper F, Harada T et al (1997) Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci USA 94:1200-12055
14. Barbaro G, Di Lorenzo G, Asti A et al (1999a) Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: ultrastructural and biochemical findings. Am J Gastroenterol 94:2198-22055
15. Barbaro G, Di Lorenzo G, Ribersani M et al (1999b) Serum ferritin and hepatic glutathione concentrations in chronic hepatitis C patients related to the hepatitis C virus genotype. J Hepatol 30:774-7822
16. Bataller R, Paik YH, Lindquist JN et al (2004) Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells. Gastroenterology 126:529-5400
17. Bernsmeier C, Duong FH, Christen V et al (2008) Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C. J Hepatol 49:429-4400
18. Bonnard C, Durand A, Peyrol S et al (2008) Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J Clin Invest 118:789-8000
19. Bose SK, Shrivastava S, Meyer K et al (2012) Hepatitis C virus activates mTOR/S6K1 signaling pathway in inhibiting IRS-1 function for insulin resistance. J Virol 86:6315-63222
20. Boudreau HE, Emerson SU, Korzeniowska A et al (2009) Hepatitis C virus (HCV) proteins induce NADPH oxidase 4 expression in a transforming growth factor beta-dependent manner: a new contributor to HCV-induced oxidative stress. J Virol 83:12934-129466
21. Brenner DA (2009) Molecular pathogenesis of liver fibrosis. Trans Am Clin Climatol Assoc 120:361-3688
22. Bruno S, Crosignani A, Maisonneuve P et al (2007) Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study. Hepatology 46:1350-13566
23. Cacoub P, Delluc A, Saadoun D et al (2008) Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand? Ann Rheum Dis 67:283-2877
24. Cardin R, Saccoccio G, Masutti F et al (2001) DNA oxidative damage in leukocytes correlates with the severity of HCV-related liver disease: validation in an open population study. J Hepatol 34:587-5922
25. Cheeseman KH, Slater TF (1993) An introduction to free radical biochemistry. Br Med Bull 49:481-4933
26. Cheng Z, Guo S, Copps K et al (2009) Foxo1 integrates insulin signaling with mitochondrial function in the liver. Nat Med 15:1307-13111
27. Dal Maso L, Franceschi S (2006) Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 15:2078-20855
28. Dalrymple LS, Koepsell T, Sampson J et al (2007) Hepatitis C virus infection and the prevalence of renal insufficiency. Clin J Am Soc Nephrol 2:715-7211
29. Dammacco F, Sansonno D (1997) Mixed cryoglobulinemia as a model of systemic vasculitis. Clin Rev Allergy Immunol 15:97-1199
30. Dammacco F, Sansonno D, Cornacchiulo V et al (1993) Hepatitis C virus infection and mixed cryoglobulinemia: a striking association. Int J Clin Lab Res 23:45-499
31. Dammacco F, Sansonno D, Piccoli C et al (2000) The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy. Semin Liver Dis 20:143-1577
32. de Mochel NS, Seronello S, Wang SH et al (2010) Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection. Hepatology 52:47-599
33. De Vita S, Quartuccio L, Fabris M (2008) Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both? Autoimmun Rev 8:95-999
34. Deng L, Adachi T, Kitayama K et al (2008) Hepatitis C virus infection induces apoptosis through a Bax-triggered, mitochondrion-mediated, caspase 3-dependent pathway. J Virol 82:10375-103855
35. Deng L, Shoji I, Ogawa W et al (2011) Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway. J Virol 85:8556-85688
36. Dolganiuc A, Oak S, Kodys K et al (2004) Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 127:1513-15244
37. Dong XC, Copps KD, Guo S et al (2008) Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. Cell Metab 8:65-766
38. D'Souza R, Sabin CA, Foster GR (2005) Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy. Am J Gastroenterol 100:1509-15155
39. El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557-25766
40. Eng FJ, Walewski JL, Klepper AL et al (2009) Internal initiation stimulates production of p8 minicore, a member of a newly discovered family of hepatitis C virus core protein isoforms. J Virol 83:3104-31144
41. Fabrizi F, Bruchfeld A, Mangano S et al (2007) Interferon therapy for HCV-associated glomerulonephritis: meta-analysis of controlled trials. Int J Artif Organs 30:212-2199
42. Farinati F, Cardin R, De Maria N et al (1995) Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol 22:449-4566
43. Fartoux L, Poujol-Robert A, Guechot J et al (2005) Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut 54:1003-10088
44. Ferri C, Marzo E, Longombardo G et al (1993) Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. Blood 81:1132-11366
45. Ferri C, Sebastiani M, Giuggioli D et al (2004) Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 33:355-3744
46. Fletcher NF, Yang JP, Farquhar MJ et al (2010) Hepatitis C virus infection of neuroepithelioma cell lines. Gastroenterology 139:1365-13744
47. Fletcher NF, Wilson GK, Murray J et al (2012) Hepatitis C virus infects the endothelial cells of the blood-brain barrier. Gastroenterology 142:634-6433
48. Forton DM, Karayiannis P, Mahmud N et al (2004) Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virol 78:5170-51833
49. Forton DM, Taylor-Robinson SD, Thomas HC (2006) Central nervous system changes in hepatitis C virus infection. Eur J Gastroenterol Hepatol 18:333-3388
50. Fox JG, Feng Y, Theve EJ et al (2010) Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. Gut 59:88-977
51. Fujino T, Nakamuta M, Yada R et al (2010) Expression profile of lipid metabolism-associated genes in hepatitis C virus-infected human liver. Hepatol Res 40:923-9299
52. Fujita N, Horiike S, Sugimoto R et al (2007) Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients. Free Radic Biol Med 42:353-3622
53. Fujita N, Sugimoto R, Ma N et al (2008) Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C. J Viral Hepat 15:498-5077
54. Furutani T, Hino K, Okuda M et al (2006) Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein. Gastroenterology 130:2087-20988
55. Garcia-Mediavilla MV, Sanchez-Campos S, Gonzalez-Perez P et al (2005) Differential contribution of hepatitis C virus NS5A and core proteins to the induction of oxidative and nitrosative stress in human hepatocyte-derived cells. J Hepatol 43:606-6133
56. Garcia-Ruiz I, Solis-Munoz P, Gomez-Izquierdo E et al (2012) Protein tyrosine phosphatases are involved in the interferon resistance associated with insulin resistance in HepG2 cells and obese mice. J Biol Chem 287:19564-195733
57. Giordano TP, Henderson L, Landgren O et al (2007) Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 297:2010-20177
58. Gisbert JP, Garcia-Buey L, Pajares JM et al (2003) Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology 125:1723-17322
59. Gisbert JP, Garcia-Buey L, Pajares JM et al (2005) Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection. Aliment Pharmacol Ther 21:653-6622
60. Gong G, Waris G, Tanveer R et al (2001) Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc Natl Acad Sci USA 98:9599-96044
61. Grover VP, Pavese N, Koh SB et al (2012) Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation. J Viral Hepat 19:e89-e966
62. Guidotti LG, Chisari FV (2006) Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol 1:23-611
63. Haddad J, Deny P, Munz-Gotheil C et al (1992) Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 339:321-3233
64. Harris C, Herker E, Farese RV Jr et al (2011) Hepatitis C virus core protein decreases lipid droplet turnover: a mechanism for core-induced steatosis. J Biol Chem 286:42615-426255
65. Herker E, Harris C, Hernandez C et al (2010) Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1. Nat Med 16:1295-12988
66. Hermine O, Lefrere F, Bronowicki JP et al (2002) Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 347:89-944
67. Hernandez-Gea V, Friedman SL (2011) Pathogenesis of liver fibrosis. Annu Rev Pathol 6:425-4566
68. Honda A, Arai Y, Hirota N et al (1999) Hepatitis C virus structural proteins induce liver cell injury in transgenic mice. J Med Virol 59:281-2899
69. Hope RG, McLauchlan J (2000) Sequence motifs required for lipid droplet association and protein stability are unique to the hepatitis C virus core protein. J Gen Virol 81:1913-19255
70. Houstis N, Rosen ED, Lander ES (2006) Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440:944-9488
71. Hu Z, Muroyama R, Kowatari N et al (2009) Characteristic mutations in hepatitis C virus core gene related to the occurrence of hepatocellular carcinoma. Cancer Sci 100:2465-24688
72. Hui JM, Sud A, Farrell GC et al (2003) Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]. Gastroenterology 125:1695-17044
73. Hussain SP, Schwank J, Staib F et al (2007) TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene 26:2166-21766
74. Ishido S, Hotta H (1998) Complex formation of the nonstructural protein 3 of hepatitis C virus with the p53 tumor suppressor. FEBS Lett 438:258-2622
75. Jeannot E, Boorman GA, Kosyk O et al (2012) Increased incidence of aflatoxin B1-induced liver tumors in hepatitis virus C transgenic mice. Int J Cancer 130:1347-13566
76. Joyce MA, Walters KA, Lamb SE et al (2009) HCV induces oxidative and ER stress, and sensitizes infected cells to apoptosis in SCID/Alb-uPA mice. PLoS Pathog 5:e10002911
77. Kamegaya Y, Hiasa Y, Zukerberg L et al (2005) Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis. Hepatology 41:660-6677
78. Kanety H, Feinstein R, Papa MZ et al (1995) Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulinstimulated tyrosine phosphorylation of IRS-1. J Biol Chem 270:23780-237844
79. Kannan RP, Hensley LL, Evers LE et al (2011) Hepatitis C virus infection causes cell cycle arrest at the level of initiation of mitosis. J Virol 85:7989-80011
80. Kao CF, Chen SY, Chen JY et al (2004) Modulation of p53 transcription regulatory activity and post-translational modification by hepatitis C virus core protein. Oncogene 23:2472-24833
81. Kawaguchi T, Yoshida T, Harada M et al (2004) Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol 165:1499-15088
82. Kawaguchi T, Ide T, Taniguchi E et al (2007) Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2. Am J Gastroenterol 102:570-5766
83. Kawamura T, Furusaka A, Koziel MJ et al (1997) Transgenic expression of hepatitis C virus structural proteins in the mouse. Hepatology 25:1014-10211
84. Kawamura H, Govindarajan S, Aswad F et al (2006) HCV core expression in hepatocytes protects against autoimmune liver injury and promotes liver regeneration in mice. Hepatology 44:936-9444
85. Kitase A, Hino K, Furutani T et al (2005) In situ detection of oxidized n-3 polyunsaturated fatty acids in chronic hepatitis C: correlation with hepatic steatosis. J Gastroenterol 40:617-6244
86. Kitay-Cohen Y, Amiel A, Hilzenrat N et al (2000) Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II. Blood 96:2910-29122
87. Klopstock N, Katzenellenbogen M, Pappo O et al (2009) HCV tumor promoting effect is dependent on host genetic background. PLoS ONE 4:e50255
88. Kobayashi M, Akuta N, Suzuki F et al (2010) Influence of amino-acid polymorphism in the core protein on progression of liver disease in patients infected with hepatitis C virus genotype 1b. J Med Virol 82:41-488
89. Korenaga M, Wang T, Li Y et al (2005) Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J Biol Chem 280:37481-374888
90. Kumar V, Kato N, Urabe Y et al (2011) Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma. Nat Genet 43:455-4588
91. Kwun HJ, Jung EY, Ahn JY et al (2001) p53-dependent transcriptional repression of p21(waf1) by hepatitis C virus NS3. J Gen Virol 82:2235-22411
92. Lan L, Gorke S, Rau SJ et al (2008) Hepatitis C virus infection sensitizes human hepatocytes to TRAIL-induced apoptosis in a caspase 9-dependent manner. J Immunol 181:4926-49355
93. Landau DA, Rosenzwajg M, Saadoun D et al (2009) The B lymphocyte stimulator receptor- ligand system in hepatitis C virus-induced B cell clonal disorders. Ann Rheum Dis 68:337-3444
94. Laplante M, Sabatini DM (2009) An emerging role of mTOR in lipid biosynthesis. Curr Biol 19:R1046-R10522
95. Leandro G, Mangia A, Hui J et al (2006) Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology 130:1636-16422
96. Lemon SM, McGivern DR (2012) Is hepatitis C virus carcinogenic? Gastroenterology 142:1274-12788
97. Lerat H, Honda M, Beard MR et al (2002) Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 122:352-3655
98. Lerat H, Kammoun HL, Hainault I et al (2009) Hepatitis C virus proteins induce lipogenesis and defective triglyceride secretion in transgenic mice. J Biol Chem 284:33466-334744
99. Li J, Rechsteiner M (2001) Molecular dissection of the 11S REG (PA28) proteasome activators. Biochimie 83:373-3833
100. Li K, Prow T, Lemon SM et al (2002) Cellular response to conditional expression of hepatitis C virus core protein in Huh7 cultured human hepatoma cells. Hepatology 35:1237-12466
101. Li Y, Boehning DF, Qian T et al (2007) Hepatitis C virus core protein increases mitochondrial ROS production by stimulation of Ca2+ uniporter activity. Faseb J 21:2474-24855
102. Liang Y, Shilagard T, Xiao SY et al (2009) Visualizing hepatitis C virus infections in human liver by two-photon microscopy. Gastroenterology 137:1448-14588
103. Lin W, Tsai WL, Shao RX et al (2010) Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB- dependent manner. Gastroenterology 138:2509-25188
104. Lok AS, Everhart JE, Wright EC et al (2011) Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C. Gastroenterology 140:840-8499
105. Lowell BB, Shulman GI (2005) Mitochondrial dysfunction and type 2 diabetes. Science 307:384-3877
106. Luedde T, Schwabe RF (2011) NF-kappaB in the liver-linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 8:108-1188
107. Lunel F, Musset L, Cacoub P et al (1994) Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 106:1291-13000
108. Machado MV, Oliveira AG, Cortez-Pinto H (2011) Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients. J Gastroenterol Hepatol 26:1361-13677
109. Machida K, Cheng KT, Sung VM et al (2004) Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci USA 101:4262-42677
110. Machida K, Cheng KT, Lai CK et al (2006) Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation. J Virol 80:7199-72077
111. Machida K, Tsukamoto H, Mkrtchyan H et al (2009) Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog. Proc Natl Acad Sci USA 106:1548-15533
112. Majumder M, Ghosh AK, Steele R et al (2001) Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner. J Virol 75:1401-14077
113. Masaki T, Suzuki R, Murakami K et al (2008) Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles. J Virol 82:7964-79766
114. Mason AL, Lau JY, Hoang N et al (1999) Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 29:328-3333
115. Mayhew CN, Carter SL, Fox SR et al (2007) RB loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis. Gastroenterology 133:976-9844
116. Mazzocca A, Sciammetta SC, Carloni V et al (2005) Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells. J Biol Chem 280:11329-113399
117. McClendon AK, Dean JL, Ertel A et al (2011) RB and p53 cooperate to prevent liver tumorigenesis in response to tissue damage. Gastroenterology 141:1439-14500
118. McGivern DR, Lemon SM (2009) Tumor suppressors, chromosomal instability, and hepatitis C virus-associated liver cancer. Annu Rev Pathol 4:399-4155
119. McGivern DR, Villanueva RA, Chinnaswamy S et al (2009) Impaired replication of hepatitis C virus containing mutations in a conserved NS5B retinoblastoma protein-binding motif. J Virol 83:7422-74333
120. Merkle M, Ribeiro A, Koppel S et al (2012) TLR3-dependent immune regulatory functions of human mesangial cells. Cell Mol Immunol 9:334-3400
121. Miki D, Ochi H, Hayes CN et al (2011) Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers. Nat Genet 43:797-8000
122. Milward A, Mankouri J, Harris M (2010) Hepatitis C virus NS5A protein interacts with betacatenin and stimulates its transcriptional activity in a phosphoinositide-3 kinase-dependent fashion. J Gen Virol 91:373-3811
123. Misiani R, Bellavita P, Fenili D et al (1994) Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 330:751-7566
124. Mitsuyoshi H, Itoh Y, Sumida Y et al (2008) Evidence of oxidative stress as a cofactor in the development of insulin resistance in patients with chronic hepatitis C. Hepatol Res 38:348-3533
125. Miyamoto H, Moriishi K, Moriya K et al (2007) Involvement of the PA28gamma-dependent pathway in insulin resistance induced by hepatitis C virus core protein. J Virol 81:1727-17355
126. Miyanari Y, Atsuzawa K, Usuda N et al (2007) The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 9:1089-10977
127. Monetti M, Levin MC, Watt MJ et al (2007) Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab 6:69-788
128. Monti G, Pioltelli P, Saccardo F et al (2005) Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. Arch Intern Med 165:101-1055
129. Moriishi K, Okabayashi T, Nakai K et al (2003) Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein. J Virol 77:10237-102499
130. Moriishi K, Mochizuki R, Moriya K et al (2007) Critical role of PA28gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis. Proc Natl Acad Sci USA 104:1661-16666
131. Moriishi K, Shoji I, Mori Y et al (2010) Involvement of PA28gamma in the propagation of hepatitis C virus. Hepatology 52:411-4200
132. Moriya K, Fujie H, Shintani Y et al (1998) The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4:1065-10677
133. Moriya K, Nakagawa K, Santa T et al (2001a) Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 61:4365-43700
134. Moriya K, Todoroki T, Tsutsumi T et al (2001b) Increase in the concentration of carbon 18 monounsaturated fatty acids in the liver with hepatitis C: analysis in transgenic mice and humans. Biochem Biophys Res Commun 281:1207-12122
135. Mousseau G, Kota S, Takahashi V et al (2011) Dimerization-driven interaction of hepatitis C virus core protein with NS3 helicase. J Gen Virol 92:101-1111
136. Munakata T, Nakamura M, Liang Y et al (2005) Down-regulation of the retinoblastoma tumor suppressor by the hepatitis C virus NS5B RNA-dependent RNA polymerase. Proc Natl Acad Sci USA 102:18159-181644
137. Munakata T, Liang Y, Kim S et al (2007) Hepatitis C virus induces E6AP-dependent degradation of the retinoblastoma protein. PLoS Pathog 3:1335-13477
138. Muzzi A, Leandro G, Rubbia-Brandt L et al (2005) Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients. J Hepatol 42:41-466
139. Naas T, Ghorbani M, Alvarez-Maya I et al (2005) Characterization of liver histopathology in a transgenic mouse model expressing genotype 1a hepatitis C virus core and envelope proteins 1 and 2. J Gen Virol 86:2185-21966
140. Nakamoto S, Imazeki F, Fukai K et al (2010) Association between mutations in the core region of hepatitis C virus genotype 1 and hepatocellular carcinoma development. J Hepatol 52:72-788
141. Oem JK, Jackel-Cram C, Li YP et al (2008) Activation of sterol regulatory element-binding protein 1c and fatty acid synthase transcription by hepatitis C virus non-structural protein 2. J Gen Virol 89:1225-12300
142. Ohata K, Hamasaki K, Toriyama K et al (2003) Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer 97:3036-30433
143. Okada K, Takishita Y, Shimomura H et al (1996) Detection of hepatitis C virus core protein in the glomeruli of patients with membranous glomerulonephritis. Clin Nephrol 45:71-766
144. Okuda M, Li K, Beard MR et al (2002) Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 122:366-3755
145. Pal S, Sullivan DG, Kim S et al (2006) Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism. Gastroenterology 130:1107-11166
146. Park CY, Choi SH, Kang SM et al (2009) Nonstructural 5A protein activates beta-catenin signaling cascades: implication of hepatitis C virus-induced liver pathogenesis. J Hepatol 51:853-8644
147. Patton HM, Patel K, Behling C et al (2004) The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients. J Hepatol 40:484-4900
148. Pawlotsky JM, Ben Yahia M, Andre C et al (1994) Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 19:841-8488
149. Pekow JR, Bhan AK, Zheng H et al (2007) Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer 109:2490-24966
150. Pereira Tde A, Witek RP, Syn WK et al (2010) Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinoma. Lab Invest 90:1690-17033
151. Perlemuter G, Sabile A, Letteron P et al (2002) Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. Faseb J 16:185-1944
152. Persico M, Masarone M, La Mura V et al (2009) Clinical expression of insulin resistance in hepatitis C and B virus-related chronic hepatitis: differences and similarities. World J Gastroenterol 15:462-4666
153. Polyak SJ, Khabar KS, Rezeiq M et al (2001) Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy. J Virol 75:6209-62111
154. Poynard T, Ratziu V, McHutchison J et al (2003) Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C. Hepatology 38:75-855
155. Qadri I, Iwahashi M, Simon F (2002) Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3. Biochim Biophys Acta 1592:193-2044
156. Qiu W, Wang X, Leibowitz B et al (2011) PUMA-mediated apoptosis drives chemical hepatocarcinogenesis in mice. Hepatology 54:1249-12588
157. Raimondi S, Bruno S, Mondelli MU et al (2009) Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. J Hepatol 50:1142-11544
158. Ratziu V, Munteanu M, Charlotte F et al (2003) Fibrogenic impact of high serum glucose in chronic hepatitis C. J Hepatol 39:1049-10555
159. Rubbia-Brandt L, Leandro G, Spahr L et al (2001) Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3. Histopathology 39:119-1244
160. Ryu SH, Fan X, Xu Y et al (2009) Lack of association between genotypes and subtypes of HCV and occurrence of hepatocellular carcinoma in Egypt. J Med Virol 81:844-8477
161. Saadoun D, Suarez F, Lefrere F et al (2005) Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity? Blood 105:74-766
162. Saadoun D, Resche-Rigon M, Thibault V et al (2006) Antiviral therapy for hepatitis C virus- associated mixed cryoglobulinemia vasculitis: a long-term followup study. Arthritis Rheum 54:3696-37066
163. Saadoun D, Delluc A, Piette JC et al (2008) Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis. Curr Opin Rheumatol 20:23-288
164. Saito T, Owen DM, Jiang F et al (2008) Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454:523-5277
165. Sansonno D, Cornacchiulo V, Iacobelli AR et al (1995) Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. Hepatology 21:305-3122
166. Sansonno D, De Vita S, Iacobelli AR et al (1998) Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol 160:3594-36011
167. Sansonno D, Lauletta G, Nisi L et al (2003) Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia. Clin Exp Immunol 133:275-2822
168. Sato Y, Kato J, Takimoto R et al (2006) Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB. Gut 55:1801-18088
169. Schulze-Krebs A, Preimel D, Popov Y et al (2005) Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cells. Gastroenterology 129:246-2588
170. Sene D, Limal N, Cacoub P (2004) Hepatitis C virus-associated extrahepatic manifestations: a review. Metab Brain Dis 19:357-3811
171. Seto WK, Lai CL, Fung J et al (2010) Natural history of chronic hepatitis C: genotype 1 versus genotype 6. J Hepatol 53:444-4488
172. Shi ST, Polyak SJ, Tu H et al (2002) Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins. Virology 292:198-2100
173. Shintani Y, Fujie H, Miyoshi H et al (2004) Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 126:840-8488
174. Shirakura M, Murakami K, Ichimura T et al (2007) E6AP ubiquitin ligase mediates ubiquitylation and degradation of hepatitis C virus core protein. J Virol 81:1174-11855
175. Simo R, Lecube A, Genesca J et al (2006) Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection. Diabetes Care 29:2462-24666
176. Stokes MB, Chawla H, Brody RI et al (1997) Immune complex glomerulonephritis in patients coinfected with human immunodeficiency virus and hepatitis C virus. Am J Kidney Dis 29:514-5255
177. Storozhevykh TP, Senilova YE, Persiyantseva NA et al (2007) Mitochondrial respiratory chain is involved in insulin-stimulated hydrogen peroxide production and plays an integral role in insulin receptor autophosphorylation in neurons. BMC Neurosci 8:844
178. Street A, Macdonald A, McCormick C et al (2005) Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular beta-catenin and stimulation of beta-catenin-responsive transcription. J Virol 79:5006-50166
179. Su AI, Pezacki JP, Wodicka L et al (2002) Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci USA 99:15669-156744
180. Sun B, Karin M (2008) NF-kappaB signaling, liver disease and hepatoprotective agents. Oncogene 27:6228-62444
181. Suzuki R, Moriishi K, Fukuda K et al (2009) Proteasomal turnover of hepatitis C virus core protein is regulated by two distinct mechanisms: a ubiquitin-dependent mechanism and a ubiquitin- independent but PA28gamma-dependent mechanism. J Virol 83:2389-23922
182. Tai DI, Tsai SL, Chen YM et al (2000) Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis. Hepatology 31:656-6644
183. Tanaka M, Nagano-Fujii M, Deng L et al (2006) Single-point mutations of hepatitis C virus NS3 that impair p53 interaction and anti-apoptotic activity of NS3. Biochem Biophys Res Commun 340:792-7999
184. Tanaka N, Moriya K, Kiyosawa K et al (2008) PPARalpha activation is essential for HCV core protein- induced hepatic steatosis and hepatocellular carcinoma in mice. J Clin Invest 118:683-6944
185. Taniguchi H, Kato N, Otsuka M et al (2004) Hepatitis C virus core protein upregulates transforming growth factor-beta 1 transcription. J Med Virol 72:52-599
186. Thoren F, Romero A, Lindh M et al (2004) A hepatitis C virus-encoded, nonstructural protein (NS3) triggers dysfunction and apoptosis in lymphocytes: role of NADPH oxidase-derived oxygen radicals. J Leukoc Biol 76:1180-11866
187. Thorgeirsson SS, Grisham JW (2002) Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31:339-3466
188. Tsutsumi T, Matsuda M, Aizaki H et al (2009) Proteomics analysis of mitochondrial proteins reveals overexpression of a mitochondrial protein chaperon, prohibitin, in cells expressing hepatitis C virus core protein. Hepatology 50:378-3866
189. Veldt BJ, Chen W, Heathcote EJ et al (2008) Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology 47:1856-18622
190. Walters KA, Syder AJ, Lederer SL et al (2009) Genomic analysis reveals a potential role for cell cycle perturbation in HCV-mediated apoptosis of cultured hepatocytes. PLoS Pathog 5:e10002699
191. Wang D, Sul HS (1998) Insulin stimulation of the fatty acid synthase promoter is mediated by the phosphatidylinositol 3-kinase pathway. Involvement of protein kinase B/Akt. J Biol Chem 273:25420-254266
192. Wang AG, Lee DS, Moon HB et al (2009a) Non-structural 5A protein of hepatitis C virus induces a range of liver pathology in transgenic mice. J Pathol 219:253-2622
193. Wang CS, Yao WJ, Chang TT et al (2009b) The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses. Cancer Epidemiol Biomarkers Prev 18:2054-20600
194. Wang N, Liang Y, Devaraj S et al (2009c) Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells. J Virol 83:9824-98344
195. Waris G, Tardif KD, Siddiqui A (2002) Endoplasmic reticulum (ER) stress: hepatitis C virus induces an ER-nucleus signal transduction pathway and activates NF-kappaB and STAT-3. Biochem Pharmacol 64:1425-14300
196. Waris G, Livolsi A, Imbert V et al (2003) Hepatitis C virus NS5A and subgenomic replicon activate NF-kappaB via tyrosine phosphorylation of IkappaBalpha and its degradation by calpain protease. J Biol Chem 278:40778-407877
197. Waris G, Felmlee DJ, Negro F et al (2007) Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress. J Virol 81:8122-81300
198. Westin J, Lagging M, Dhillon AP et al (2007) Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection. J Viral Hepat 14:29-355
199. Wornle M, Schmid H, Banas B et al (2006) Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol 168:370-3855
200. Xu J, Kim HT, Ma Y et al (2008) Trauma and hemorrhage-induced acute hepatic insulin resistance: dominant role of tumor necrosis factor-alpha. Endocrinology 149:2369-23822
201. Yamaguchi A, Tazuma S, Nishioka T et al (2005) Hepatitis C virus core protein modulates fatty acid metabolism and thereby causes lipid accumulation in the liver. Dig Dis Sci 50:1361-13711
202. Yamaji S, Zhang M, Zhang J et al (2010) Hepatocyte-specific deletion of DDB1 induces liver regeneration and tumorigenesis. Proc Natl Acad Sci USA 107:22237-222422
203. Yu T, Robotham JL, Yoon Y (2006) Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc Natl Acad Sci USA 103:2653-26588
204. Zhang J, Gao Z, Yin J et al (2008) S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK2. J Biol Chem 283:35375-353822